MBL Venture Capital

MBL Venture Capital

Japanese venture capital firm investing on biotechnology and life science startups.

Edit ID  10204568 

Khadidiatou Amirou
Khadidiatou Amirou edited on 10 Mar, 2019
Edits made to:
Infobox (+3 properties)
Description (+83 characters)
Article (+1056 characters)
People (+3 rows) (+6 cells) (+74 characters)
Companies (+5 rows) (+5 cells) (+55 characters)
Categories (+1 topics)
Topic thumbnail

MBL Ventures MBL Venture Capital

Japanese venture capital firm investing on biotechnology and life science startups.

Article

MBL Venture Capital, also known as mblVC, is a venture capital firm founded in 2000. The firm is a subsidiary of Medical & Biological Laboratories Co., Ltd., a Japanese company that specializes in the research and manufacture of in-vitro diagnostics (IVDs) and research reagents. mblVC is primarily based in Tokyo, Japan although it also has an additional office in Nagoya, Japan. The firm’s most recent investment is in Sentien Biotechnologies during September 2018, a company developing blood conditioning therapies for patients with critical illnesses.

Funding

mblVC primarily funds companies that are based in Japan and the United States, although it also invests in companies from Europe. The firm specializes on investing in companies that are operating in these industries: biotechnology, life science, pharmaceuticals, and healthcare information technology. It finances companies in various stages of development, from seed-stage to pre-IPO. The firm provides $1-2 million for initial investment and $2-3 million for each portfolio company in total.

People

Name
Role
Related Golden topics

Masako Hashimoto

Senior Manager

Masaya Ishibasi

Manager

Yasuyo Kayama

President

Companies

Company
CEO
Location
Products/Services

Agensys

ChemNavigator

Cytokinetics

GreenPeptide

NanoCarrier

Infobox
Is a
Company
Industry
Venture capital
Categories
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.